Device Cell Analyzers

Bd Affirm Vpiii Microbial Identification Test

Payments companies reported to CMS as associated with Bd Affirm Vpiii Microbial Identification Test. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1,985associated payments (2023-2025)
83clinicians with associated payments
2companies reporting

By year

2023 $1,867
2024 $35.50
2025 $83.16

Payments reported as associated with Bd Affirm Vpiii Microbial Identification Test, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Obstetrics & Gynecology $438
Physician Assistant $351
Family $267
Family Medicine $247
Internal Medicine $156
Anatomic Pathology & Clinical Pathology $83.16

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Bd Affirm Vpiii Microbial Identification Test

These are the largest totals companies reported as associated with Bd Affirm Vpiii Microbial Identification Test. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Michael Wagoner Tampa, FL Anatomic Pathology & Clinical Pathology $83.16
Heidi Fite Buckley, MI Physician Assistant $51.24
Kori Marvin Buckley, MI Physician Assistant $51.23
Mitzie Hewitt Buckley, MI Family Medicine $51.23
Lindsey Campion Centennial, CO Family $44.19
Emilie Briggs Grand Rapids, MI Physician Assistant $39.74
Jessica Clark Columbus, OH Psychiatric/Mental Health (Nurse Practitioner) $39.74
Matthew Larsen Cedar Springs, MI Physician Assistant $39.74
Thomas Cox Cedar Springs, MI Physician Assistant $39.74
Kirsten Oosterbaan Greenville, MI Medical $39.74

Prescribed Bd Affirm Vpiii Microbial Identification Test?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.